Total Funding
31
65
Total FundingSeed raised
Growth Score 31 in past quarter
-3 pts
Heat Score 65 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
163960
Direct Allergy is a medical service organization that provides physicians with an advanced allergy testing and treatment services.
Jay Gruhlkey: Co-Founder & Chief Medical Officer- Matthew J. Minnaugh: Chief Financial Officer
About the Company
Direct Allergy is a medical service organization that provides physicians with on-site allergy and asthma testing with customized immunotherapy treatments. Immunotherapy is a process that helps desensitize an allergy patient to the indoor and outdoor allergens that trigger symptoms, such as itchy, watery eyes, and sneezing. An ideal alternative to
expensive, ineffective over the counter allergy medications, immunotherapy completely eliminates allergies, helping allergy sufferers spend more time doing the things they love.
Direct Allergy was by Robert S. Schultz, Jay Gruhlkey, and Joseph Zajac founded in 2012 and is headquartered in Erie, Pennsylvania, United States.
